A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Clinical trial NCT07501702 · RECRUITING

Trial details

NCT number: NCT07501702
Sponsor: Vertex Pharmaceuticals Incorporated
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2026-05-13
Primary completion: 2029-03-02
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.